| NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors GD Demetri, M Von Mehren, CR Antonescu, RP DeMatteo, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 8 (Suppl_2), S-1-S-41, 2010 | 1268 | 2010 |
| Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized … GD Demetri, M Von Mehren, RL Jones, ML Hensley, SM Schuetze, ... Journal of Clinical Oncology 34 (8), 786, 2016 | 817 | 2016 |
| Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 16 (5), 536-563, 2018 | 603 | 2018 |
| R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II … AS Pappo, SR Patel, J Crowley, DK Reinke, KP Kuenkele, SP Chawla, ... Journal of Clinical Oncology 29 (34), 4541, 2011 | 362 | 2011 |
| Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma: results from a multicenter study BS Kahl, NL Bartlett, JP Leonard, L Chen, K Ganjoo, ME Williams, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 332 | 2010 |
| Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ... The Lancet 394 (10197), 478-487, 2019 | 321 | 2019 |
| Soft tissue sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, EU Conrad, ... Journal of the National Comprehensive Cancer Network 14 (6), 758-786, 2016 | 314 | 2016 |
| Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre … WD Tap, Z Papai, BA Van Tine, S Attia, KN Ganjoo, RL Jones, S Schuetze, ... The lancet oncology 18 (8), 1089-1103, 2017 | 265 | 2017 |
| Using cereal grain winter cover crops to reduce groundwater nitrate contamination in the mid-Atlantic coastal plain KW Staver, RB Brinsfield Journal of Soil and Water Conservation 53 (3), 230-240, 1998 | 253 | 1998 |
| Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial WD Tap, AJ Wagner, P Schöffski, J Martin-Broto, A Krarup-Hansen, ... Jama 323 (13), 1266-1276, 2020 | 229 | 2020 |
| NCCN guidelines insights: soft tissue sarcoma, version 1.2021: featured updates to the NCCN guidelines M von Mehren, JM Kane, MM Bui, E Choy, M Connelly, S Dry, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 18 (12), 1604-1612, 2020 | 224 | 2020 |
| Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma LE Davis, V Bolejack, CW Ryan, KN Ganjoo, ET Loggers, S Chawla, ... Journal of Clinical Oncology 37 (16), 1424, 2019 | 208 | 2019 |
| A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma … AS Pappo, G Vassal, JJ Crowley, V Bolejack, PCW Hogendoorn, ... Cancer 120 (16), 2448-2456, 2014 | 199 | 2014 |
| Soft tissue sarcoma GD Demetri, S Antonia, RS Benjamin, MM Bui, ES Casper, EU Conrad, ... Journal of the National Comprehensive Cancer Network 8 (6), 630-674, 2010 | 167 | 2010 |
| Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines M Von Mehren, RS Benjamin, MM Bui, ES Casper, EU Conrad, ... Journal of the National Comprehensive Cancer Network 10 (8), 951-960, 2012 | 166 | 2012 |
| Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma SP Chawla, LD Cranmer, BA Van Tine, DR Reed, SH Okuno, JE Butrynski, ... Journal of Clinical Oncology 32 (29), 3299, 2014 | 164 | 2014 |
| Non‐Hodgkin lymphoma of the breast K Ganjoo, R Advani, MR Mariappan, A McMillan, S Horning Cancer 110 (1), 25-30, 2007 | 161 | 2007 |
| Clinically relevant molecular subtypes in leiomyosarcoma X Guo, VY Jo, AM Mills, SX Zhu, CH Lee, I Espinosa, MR Nucci, S Varma, ... Clinical cancer research 21 (15), 3501-3511, 2015 | 151 | 2015 |
| Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis KN Ganjoo, CS An, MJ Robertson, LI Gordon, JA Sen, J Weisenbach, S Li, ... Leukemia & lymphoma 47 (6), 998-1005, 2006 | 140 | 2006 |
| Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery KA Kesler, KM Rieger, KN Ganjoo, M Sharma, NS Fineberg, LH Einhorn, ... The Journal of thoracic and cardiovascular surgery 118 (4), 692-701, 1999 | 133 | 1999 |
